Abstract
Diarrhea is defined as reduced stool consistency, increased water content and number of evacuations per day. A wide array of causes and pathophysiological mechanisms underlie acute and chronic forms of diarrhea. This review focuses on the major clinical aspects which should aid clinicians to diagnose chronic diarrhea. Clinical history, physical examination and stool evaluation and the predominant stool characteristic, i.e., bloody, watery, and fatty diarrhea, may narrow the differential diagnosis. Although mainly involved in acute diarrhea, many different infectious agents, including bacteria, viruses and protozoa, can be identified in chronic bloody/inflammatory diarrhea by appropriate microbiological tests and colonoscopic biopsy analysis. Osmotic diarrhea can be the result of malabsorption or maldigestion, with a subsequent passage of fat in the stool leading to steatorrhea. Secretory diarrhea is due to an increase of fluid secretion in the small bowel lumen, a mechanism often identified in gastroenteropancreatic neuroendocrine tumors. The evaluation of the fecal osmotic gap may help to characterize whether a chronic diarrhea is osmotic or secretory. Fatty diarrhea (steatorrhea) occurs if fecal fat output exceeds the absorptive/digestive capacity of the intestine. Steatorrhea results from malabsorption or maldigestion states and tests should differentiate between these two conditions. Individualized diagnostic work ups tailored on pathophysiological and clinical features are expected to reduce costs for patients with chronic diarrhea.
This is a preview of subscription content, access via your institution.


Abbreviations
- EMA:
-
Endomysial antibodies
- FD:
-
Functional diarrhea
- IBD:
-
Inflammatory bowel disease
- IBS:
-
Irritable bowel syndrome
- IBS-C:
-
Constipation predominant irritable bowel syndrome
- IBS-D:
-
Diarrhea predominant irritable bowel syndrome
- MRI:
-
Magnetic resonance imaging
- 75SeHCAT:
-
75-Seleniumhomotaurocholic acid
- tTG:
-
Tissue transglutaminase
- VIP:
-
Vasoactive intestinal polypeptide
References
Wenzl HH, Fine KD, Schiller LR, Fordtran JS (1995) Determinants of decreased fecal consistency in patients with diarrhea. Gastroenterology 108:1729–1738
Field M (2003) Intestinal ion transport and the pathophysiology of diarrhea. J Clin Invest 111:931–943
Camilleri M (2004) Chronic diarrhea: a review on pathophysiology and management for the clinical gastroenterologist. Clin Gastroenterol Hepatol 2:198–206
Palma R, Vidon N, Bernier JJ (1981) Maximal capacity for fluid absorption in human bowel. Dig Dis Sci 26:929–934
Kurose I, Pothoulakis C, LaMont JT, Anderson DC, Paulson JC, Miyasaka M, Wolf R, Granger DN (1994) Clostridium difficile toxin A-induced microvascular dysfunction. Role of histamine. J Clin Invest 94:1919–1926
Castagliuolo I, LaMont JT, Letourneau R, Kelly C, O’Keane JC, Jaffer A, Theoharides TC, Pothoulakis C (1994) Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin in rat ileum. Gastroenterology 107:657–665
Baldi F, Bianco MA, Nardone G, Pilotto A, Zamparo E (2009) Focus on acute diarrhoeal disease. World J Gastroenterol 15:3341–3348
Gadewar S, Fasano A (2005) Current concepts in the evaluation, diagnosis and management of acute infectious diarrhea. Curr Opin Pharmacol 5:559–565
Fine KD, Schiller LR (1999) AGA technical review on the evaluation and management of chronic diarrhea. Gastroenterology 116:1464–1486
Headstrom PD, Surawicz CM (2005) Chronic diarrhea. Clin Gastroenterol Hepatol 3:734–737
Schiller LR (2004) Chronic diarrhea. Gastroenterology 127:287–293
Wrenn K (1989) Fecal impaction. N Engl J Med 321:658–662
Juckett G, Trivedi R (2011) Evaluation of chronic diarrhea. Am Fam Physician 84:1119–1126
Di Sabatino A, Biancheri P, Rovedatti L, Macdonald TT, Corazza GR (2012) Recent advances in understanding ulcerative colitis. Int Emerg Med 7:103–111
Paulet P, Coffernils M (1990) Very long term diarrhoea due to Campylobacter jejuni. Postgrad Med J 66:410–411
Chetty R, Govender D (2012) Lymphocytic and collagenous colitis: an overview of so-called microscopic colitis. Nat Rev Gastroenterol Hepatol 9:209–218
Volta U, Villanacci V (2011) Celiac disease: diagnostic criteria in progress. Cell Mol Immunol 8:96–102
Volta U, De Giorgio R (2012) New understanding of gluten sensitivity. Nat Rev Gastroenterol Hepatol 9:295–299
Volta U, Granito A, Parisi C, Fabbri A, Fiorini E, Piscaglia M, Tovoli F, Grasso V, Muratori P, Pappas G, De Giorgio R (2010) Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol 44:186–190
Di Sabatino A, Corazza GR (2009) Coeliac disease. Lancet 373:1480–1493
Gasbarrini A, Corazza GR, Gasbarrini G, Montalto M, Di Stefano M, Basilisco G, Parodi A, Usai-Satta P, Vernia P, Anania C, Astegiano M, Barbara G, Benini L, Bonazzi P, Capurso G, Certo M, Colecchia A, Cuoco L, Di Sario A, Festi D, Lauritano C, Miceli E, Nardone G, Perri F, Portincasa P, Risicato R, Sorge M, Tursi A, 1st Rome H2-Breath Testing Consensus Conference Working Group (2009) Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther 29(Suppl 1):1–49
Ridolo E, Baiardini I, Meschi T, Peveri S, Nouvenne A, Dall’aglio P, Borghi L. (2012) HRQoL questionnaire evaluation in lactose intolerant patients with adverse reactions to foods. Intern Emerg Med (Epub ahead of print)
Quigley EM, Abdel-Hamid H, Barbara G, Bhatia SJ, Boeckxstaens G, De Giorgio R, Delvaux M, Drossman DA, Foxx-Orenstein AE, Guarner F, Gwee KA, Harris LA, Hungin AP, Hunt RH, Kellow JE, Khalif IL, Kruis W, Lindberg G, Olano C, Moraes-Filho JP, Schiller LR, Schmulson M, Simrén M, Tzeuton C (2012) A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome. J Clin Gastroenterol 46:356–366
Barbara G, Cremon C, Pallotti F, De Giorgio R, Stanghellini V, Corinaldesi R (2009) Postinfectious irritable bowel syndrome. J Pediatr Gastroenterol Nutr 48(Suppl 2):S95–S97
Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A (2008) Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 9:61–72
Von der Ohe MR, Camilleri M, Kvols LK, Thomforde GM (1993) Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med 329:1073–1078
Aldini R, Roda A, Festi D et al (1982) Bile acid malabsorption and bile acid diarrhea in intestinal resection. Dig Dis Sci 27:495–502
Sciarretta G, Fagioli G, Furno A et al (1987) 75Se HCAT test in the detection of bile acid malabsorption in functional diarrhoea and its correlation with small bowel transit. Gut 28:970–975
Eherer AJ, Fordtran JS (1992) Fecal osmotic gap and pH in experimental diarrhea of various causes. Gastroenterology 103:545–551
Fine KD, Fordtran JS (1992) The effect of diarrhea on fecal fat excretion. Gastroenterology 102:1936–1939
Afshar P, Redfield DC, Higginbottom PA (2010) Whipple’s disease: a rare disease revisited. Curr Gastroenterol Rep 12:263–269
Schiller LR (1995) Review article: anti-diarrhoeal pharmacology and therapeutics. Aliment Pharmacol Ther 9:87–106
Scaldaferri F, Pizzoferrato M, Ponziani FR, Gasbarrini G, Gasbarrini A. (2011) Use and indications of cholestyramine and bile acid sequestrants. Intern Emerg Med (Epub ahead of print)
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Corinaldesi, R., Stanghellini, V., Barbara, G. et al. Clinical approach to diarrhea. Intern Emerg Med 7 (Suppl 3), 255–262 (2012). https://doi.org/10.1007/s11739-012-0827-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-012-0827-4
Keywords
- Chronic diarrhea
- Osmotic diarrhea
- Secretory diarrhea
- Steatorrhea